Fulgent Genetics and Columbia University Irving Medical

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
32
Fulgent Genetics and Columbia University Irving Medical Center Partner on Expanded Carrier Screening

TEMPLE CITY, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) and the Precision Genomics Laboratory (PGL), in collaboration with the Department of Obstetrics and Gynecology, at Columbia University Irving Medical Center (CUIMC) announced today a new partnership to make on site performed, expanded carrier screening available to Columbia patients.  This unique collaboration will leverage both parties’ expertise in laboratory management, bioinformatics, clinical genetics and next-generation sequencing to deliver an expanded carrier screening test with many advantages over other currently available tests.

The PGL is jointly operated by the Institute for Genomic Medicine (IGM) and the Department of Pathology and Cell Biology and is designed to enhance patient care through genomic diagnostics, research, and education at CUIMC.

Carrier screening is a genetic test used to identify whether individuals and carrier couples are at risk for passing genetic disorders to their children. These genetic disorders may result in physical disabilities, cognitive impairment, and other severe health problems in newborn babies. Traditionally, carrier screening tests targeted couples of certain ethnic groups that have historically been at higher risk for specific genetic disorders. This approach has presented difficulties for patients who are multiracial, adopted, or are unsure of their ethnic backgrounds. To address this challenge, expanded carrier screening (ECS) was developed to test for mutations that cause hundreds of different genetic disorders regardless of a patient’s ethnicity.

Professional medical associations like the American College of Obstetricians and Gynecologists (ACOG) and the American College of Medical Genetics and Genomics (ACMG) have published guidelines on ECS and its importance in reproductive care.

“We are extremely excited to partner with such a prestigious institution in a collective effort to help improve patient care by offering expanded carrier screening as a routine test to Columbia patients,” said Brandon Perthuis, Vice President of Commercial Operations at Fulgent Genetics.   

“This collaboration will help us to bring high-quality reproductive genomic testing to our patients,” said the IGM’s David Goldstein, “and will enable the Institute for Genomic Medicine and Fulgent Genetics to leverage our strengths in genomic medicine and clinical genetics to co-develop a range of new tests in the future.”

“The Fulgent partnership is another exciting step in the evolution of precision medicine clinical testing at CUIMC and the PGL. The Department of Pathology and Cell Biology, in partnership with Fulgent, the IGM, and the Department of Obstetrics and Gynecology, looks forward to providing reproductive genomic testing to CUIMC patients,” said Dr. Kevin Roth, Chair, Department of Pathology and Cell Biology.

“We are thrilled to partner with Fulgent Genetics to bring reproductive genomic testing to our patients,” said Dr. Mary D’Alton, Chair of the Department of Obstetrics and Gynecology at CUIMC. “Prenatal diagnosis has significantly enhanced our ability to counsel patients at risk for genetic disease in advance of delivery, but carrier screening will transform our field even further. Patients who are eager to conceive are increasingly seeking genetic information to help them make informed decisions as they build their families, and our partnership with Fulgent will make this possible for many more women and couples.” Dr. Ronald Wapner, Director of Reproductive Genetics in the Department of Ob/Gyn and the IGM added “this service will allow us to continue to lead the provision of personalized medicine care in women’s health.”

About Fulgent Genetics

Fulgent Genetics is a technology company with a focus on offering comprehensive genetic testing to provide physicians with clinically actionable diagnostic information they can use to improve the quality of patient care. The company has developed a proprietary technology platform that allows it to offer a broad and flexible test menu and continually expand and improve its proprietary genetic reference library, while maintaining accessible pricing, high accuracy and competitive turnaround times. The company believes its test menu, which currently offers more genes for testing than its competitors in today’s market, enables it to provide expansive options for test customization and clinically actionable results.

Investor Relations Contacts:

The Blueshirt Group

Nicole Borsje, 415-217-2633, nborsje@blueshirtgroup.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Chord's $550 Million Exit Tightens Its Basin Focus

Updated Category News Views 35

One map pin just disappeared from Chord Energy’s corporate wall, and that matters more than the usual deal-closing confetti. Chord has completed the sale of its entire non-operated Marcellus position to POSCO International for $550 million in gross consideration. For shareholders in NASDAQ:CHRD, this is not a flashy new drilling story. It is a cleanup job, and sometimes...

Continue Reading
Flair's New Aviation Alliance Offers Options, Not Orders

Updated Category News Views 55

Aircraft shortages have a funny way of turning vague partnerships into very useful insurance policies. Flair Airlines, Phoenix Aviation Capital and Avia Solutions Group announced a Strategic Commercial Cooperation Agreement on Nov. 19, 2026, and the sensible reading is straightforward: the Canadian value carrier wants more ways to solve capacity and operational problems...

Continue Reading
Great Rail Journeys Bets Bigger on Luxury Rail in 2027

Updated Category News Views 99

A $19,995 vacation is not selling a seat on a train; it is selling relief from planning, crowds and compromise. Great Rail Journeys is leaning hard into that proposition for 2027 with two additions to its premium Landmark Collection: a Europe-heavy Orient Express and Rhône cruise pairing, plus a South Africa itinerary built around safari, Victoria Falls and rail-flavored...

Continue Reading
PayPal's New Leadership Map Puts Execution on Trial

Updated Category News Views 83

Four senior appointments and a risk-chief exit can turn a tidy strategy slide into a very real operating test. PayPal has spent months defining three-year plans, simplifying its operating model and assigning clearer accountability; on November 20, it put names beside the jobs. For NASDAQ:PYPL investors, that is more consequential than another broad promise about...

Continue Reading
Digital Diabetes Care Has a Bigger Prize Than Devices

Updated Category News Views 121

A glucose sensor is becoming less a gadget than a running conversation between patient, clinician and software. That shift matters because diabetes management is leaving the occasional clinic visit and moving into daily life, where the useful product is not merely a reading but a pattern someone can act on. The sector deserves attention from investors, but it also...

Continue Reading
S&P Global's UBS AI Conference Slot Deserves Attention

Updated Category News Views 80

Thirty Minutes Can Still Matter A half-hour fireside chat is not a quarterly earnings call, and anybody treating it like one is setting themselves up for disappointment. Still, S&P Global CEO Martina Cheung appearing at the UBS Global Technology and AI Conference on December 2 deserves a spot on the calendar for owners of NYSE:SPGI. This is a company sitting in the middle...

Continue Reading
Automus and Google Cloud Put Agents to Work on Oracle

Updated Category News Views 96

Oracle back offices are where shiny AI promises go to earn their keep, or get buried under a mountain of integrations. Automus Consulting’s newly announced collaboration with Google Cloud, unveiled November 20 at Oracle AI World, is aimed squarely at that messy middle. The firm wants to combine its Oracle implementation experience with Google Cloud infrastructure and...

Continue Reading
GEYOTO’s RE+ Debut Shows Demand, Not Yet Scale Proof

Updated Category News Views 5

Desert-colored booths do not pay invoices, but a nearly sold-out stash of spare units is a lot more useful than the usual trade-show applause. GEYOTO’s first RE+ appearance, held November 17–19 at the Las Vegas Convention Center, produced the kind of early evidence a young energy-products brand needs: people stopped, handled the equipment, asked questions, made...

Continue Reading
Allooloo's 100M Calls Test Capital Markets AI Data

Updated Category News Views 55

Forty-one point nine thousand issuers is a lot of financial clutter to keep straight, and Allooloo says its machines are getting called on to do precisely that at industrial scale. The Vancouver-based company reported on November 20 that its capital-markets data products now receive 100 million AI-agent calls a month—roughly 3.4 million daily, or 39 per second. That is...

Continue Reading
Trump's Reagan Forum Speech Puts Defense in Focus Again

Updated Category News Views 92

A December podium in Simi Valley has suddenly become a market-relevant appointment. The Ronald Reagan Presidential Foundation and Institute says President Donald J. Trump will deliver the keynote at the 2026 Reagan National Defense Forum on Friday, December 4, at 3:00 p.m. Pacific time, or 6:00 p.m. Eastern. That is the whole hard fact pattern so far. No agenda, no...

Continue Reading

Top 5 Most Recently Viewed Articles

Donnette Irving Takes Charge of Navis Pack & Ship Atlanta

Updated Category News Views 179

Donnette Irving Takes Charge of Navis Pack & Ship Atlanta Annex Brands, Inc. is expanding its presence in the oversized freight shipping and crating sector through recent developments at the Navis Pack & Ship location in Atlanta. The transition of ownership marks an exciting new chapter for the established franchise, now led by Donnette Irving, who is determined to uphold...

Continue Reading
Impact of EU’s Urban Wastewater Directive on Finland’s Pharmaceutical Industry

Updated Category News Views 175

Understanding the EU’s Urban Wastewater Treatment Directive The newly enforced Urban Wastewater Treatment Directive by the EU, effective from January 1, 2025, carries significant implications for various industries, particularly pharmaceuticals. This directive requires manufacturers in the pharmaceutical, cosmetics, and hygiene sectors to take charge of the costs...

Continue Reading
Innovations in OpenTelemetry Transform Digital Resilience for Businesses

Updated Category News Views 200

Enhancing Observability with OpenTelemetry Innovations New observability innovations empower organizations to apply OpenTelemetry to large-scale environments with complete business visibility Splunk, the cybersecurity and observability leader, has unveiled groundbreaking innovations designed to improve the OpenTelemetry experience. These advancements equip organizations...

Continue Reading
Abeona Therapeutics Expands Workforce with New Stock Grants

Updated Category News Views 158

Abeona Therapeutics Enhances Employee Inducement Programs Abeona Therapeutics Inc. has recently made significant strides in its workforce development by offering new equity awards to non-executive employees who joined the company. This move aligns with the company's commitment to fostering a dynamic work environment and was sanctioned under Nasdaq Listing Rule 5635(c)(4)....

Continue Reading
MIND Technology, Inc. Achieves Impressive Fiscal Growth

Updated Category News Views 190

MIND Technology, Inc. Reports Strong Fiscal Growth in Fourth Quarter MIND Technology, Inc. (NASDAQ: MIND), a leading provider of technology solutions for marine industries, recently revealed its financial performance for the fourth quarter and year-end results. The company reported noteworthy revenues, highlighting impressive growth compared to previous quarters. Revenue...

Continue Reading